Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Last Updated on September 6, 2016 by Joseph Gut – thasso

Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

No comments yet